Target intelligence / Profile preview

Aerobic glycolysis pathway (null)

Target
null
Molecular classification
Other (metabolic pathway)
01

Overview

Aerobic glycolysis refers to the metabolic pathway in which glucose is converted to pyruvate with the concurrent generation of ATP, even in the presence of sufficient oxygen to support oxidative phosphorylation. Unlike the classic model where glucose is fully oxidized through the citric acid cycle under aerobic conditions, some cells (notably cancer cells and activated immune cells) preferentially metabolize glucose to lactate despite oxygen availability—a phenomenon called the Warburg effect. The pathway involves a sequence of enzymatic reactions (including hexokinase, phosphofructokinase-1, and pyruvate kinase) and is crucial for rapid ATP production, biosynthesis, and cellular proliferation. As a complex pathway rather than a single target, therapeutic strategies aim at inhibiting specific glycolytic enzymes rather than the pathway as a whole.

Other names
Aerobic glycolysisGlycolytic pathway under aerobic conditionsWarburg effect (in cancer contexts)
02

Mechanism of action

null

03

Biological functions

Energy production (ATP generation)Glucose metabolismSupport of cellular proliferation (notably in cancer and activated immune cells)Redox balance (NAD+/NADH regeneration)Regulation of metabolite availability for biosynthetic pathways
04

Disease associations

Cancer (through the Warburg effect)Other (e.g., in immune cell activation, brain metabolism)
05

Safety considerations

Systemic inhibition of glycolysis can cause hypoglycemia, lactic acidosis, and toxicity to normal proliferative cellsTargeting glycolytic enzymes may have off-target effects in healthy tissues with high glycolytic rates (e.g., brain, muscle, immune cells)
06

Biomarkers

Increased glucose uptake (FDG-PET imaging, especially in oncology)Lactate productionExpression of glycolytic enzymes (e.g., hexokinase II, pyruvate kinase M2) in tissues

Beyond the preview

Go deeper on Aerobic glycolysis pathway (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aerobic glycolysis pathway (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call